Marinomed Biotech AG announces results for the first half year of 2025

• Revenues amounted to EUR 7.2 million in the first half of 2025 (H1 2024: EUR 2.4 Mio.)
• EBIT of EUR 21.0 Mio., which includes a restructuring gain
• Financing secured by the latest capital measures

The full press release is available here: